Publication | Open Access
Type I Interferons in the Treatment of Pancreatic Cancer
79
Citations
43
References
2007
Year
The antitumor activity of IFN-beta is more potent than IFN-alpha in pancreatic cancer cell lines through the induction of apoptosis. Further studies should investigate in vivo whether the intensity and distribution of IFNAR-1 and IFNAR-2c may predict the response to therapy with IFN-alpha and IFN-beta in pancreatic cancer.
| Year | Citations | |
|---|---|---|
Page 1
Page 1